Computational RNA Design and Delivery Summit on June 25-26, 2025 in Boston, United States

Returning for the 2nd year, the Computational RNA Design and Delivery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and key academic opinion leaders committed to training and validating machine learning and artificial intelligence algorithms to accelerate RNA design and delivery with improved efficacy, translation efficiency and specificity.

Following Nobel Prize recognition in 2024, and huge collaborations such as that between Moderna and OpenAI as well as Gensaic and Novo Nordisk, computational approaches such as artificial intelligence and machine continue to dominate large investments and partnerships within the RNA community - highlighting their promise for driving more therapeutically relevant RNAs towards the clinic.

Join Sanofi, Strand Therapeutics, CSL Seqirus, and many others at the 2nd Computational RNA Design and Delivery Summit to hear scientific, technical insights on AI and data science innovations for unlocking the discovery of therapeutically-relevant RNAs and new delivery chemistries for advancing efficacious medicines towards approval.

URLs:

Tickets: https://go.evvnt.com/2951613-2?pid=10008

Brochure: https://go.evvnt.com/2951613-3?pid=10008

Time: 9:00 AM - 5:00 PM

Prices:

Drug Developer - Conference Only: USD 2999.00,

Academic - Conference Only: USD 2599.00,

Solution Providers - Conference Only: USD 3699.00

Speakers: Amy Moody, Principal Scientist , Avidity Biosciences, Benjamin Holmes, Director, Data Sciences, Orbital Therapeutics, Dan Shores, Partner, Rothwell Figg, Eduardo Eyras, Professor and EMBL-Australia Group Leader, Australian National University, Frank Hidalgo, Senior Machine Learning Scientist, Strand Therapeutics, Jacob Miner, Senior Scientist, mRNA Machine Learning, Sanofi, Jasdave Chahal, Founder and Chief Scientist, Tiba Biotech, Jeff Ozdemir, Head, Platform, Kernal Biologics, Jonathan Hsu, Chief Technology Officer, Gensaic, Kokulapalan Wimalanathan, Senior Bioinformatics Scientist, Atalanta Therapeutics, Lingtao Peng, Director, Head, Molecular, Cellular and Synthetic Biology, CSL Seqirus, Marcus Gibson, Associate Director, Hit-To-Lead Optimization Platform, Omega Therapeutics, Nabeel Ahmed, Senior Scientist, Bioinformatics, Moderna, Niles Pierce, MacArthur Professor, Applied and Computational Mathematics and Bioengineering, Executive Officer, Biology and Biological Engineering, California Institute of Technology, Sichong Peng, Bioinformatics Scientist, Eclipsebio, Sizhen Li, Computational Scientist Lead, Sanofi, Yingxin Cao, Machine Learning Scientist, Shape Therapeutics, Yupeng Li, Head, Data Science, Zipcode Bio